ADMA Biologics, Inc. (ADMA) vs Clover Health Investments, Corp. (CLOV)

A side-by-side comparison of ADMA Biologics, Inc. and Clover Health Investments, Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ADMA vs CLOV

growth of $100 · dividends reinvested · last 6y
ADMA +248.6% (+23.1%/yr)CLOV -53.6% (-12.0%/yr)ADMA compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100202120222023202420252026$349$46
ADMA CLOV

ADMA vs CLOV: by the numbers

  • •CLOV is the larger company ($2.40B vs $2.36B market cap).
  • •ADMA is profitable (32.98% net margin) while CLOV runs a net loss (-0.74%).
  • •ADMA grew revenue faster over the past five years (54.55% vs 21.18% CAGR).

Metrics side by side

Valuation

MetricADMACLOV
P/E ratio14.56N/A
Forward P/E12.7982.62
P/S ratio4.610.97
P/B ratio5.786.38
EV / EBITDA10.75N/A
FCF yield4.93%3.09%

Profitability

MetricADMACLOV
Gross margin64.71%18.57%
Operating margin42.26%-0.74%
Net margin32.98%-0.74%
ROE41.39%-4.88%
ROIC27.60%-4.62%

Growth (annualized)

MetricADMACLOV
Revenue CAGR (5Y)54.55%21.18%
Total return CAGR (5Y)54.74%-8.36%

Frequently asked

Which has grown faster, ADMA or CLOV?
Over the past five years, ADMA grew revenue faster — ADMA at a 54.55% CAGR versus CLOV at 21.18%.
Is ADMA or CLOV more profitable?
ADMA runs the higher net margin — ADMA at 32.98% versus CLOV at -0.74%.
How have ADMA and CLOV total returns compared?
Over the past 5 years, ADMA delivered 54.74% and CLOV delivered -8.36% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.